Original site: www.cdc.gov/nhsn/hai-report/data-tables-adult/table-13.html | RestoredCDC.org is an independent project, not affiliated with CDC or any federal entity. Visit CDC.gov for free official information. Due to archival on January 6, 2025, recent outbreak data is unavailable. Videos are not restored. Access data.restoredcdc.org for restored data. Use of this site implies acceptance of this disclaimer.

[More]
About Us Report Bug

RestoredCDC.org Comparison

Removed: Line removed from cdc.gov. Specific word removals are highlighted.
Added: Line added to cdc.gov. Specific word additions are highlighted.
Injected: Line or disclaimer added by RestoredCDC.org.
Unchanged: Line unchanged.
Original site: www.cdc.gov/nhsn/hai-report/data-tables-adult/table-13.html | RestoredCDC.org is an independent project, not affiliated with CDC or any federal entity. Visit CDC.gov for free official information. Due to archival on January 6, 2025, recent outbreak data is unavailable. Videos are not restored. Access data.restoredcdc.org for restored data. Use of this site implies acceptance of this disclaimer.
[More]
About Us Report Bug Compare Content
Skip directly to site content Skip directly to search
Español | Other Languages
Here's how you know
An official website of the United States government Here's how you know
Healthcare-Associated Infections (HAIs)
Healthcare-Associated Infections (HAIs)
Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People Healthcare-Associated Infections (HAIs)
Search
Search Menu Navigation Menu
× Search NHSN
Search NHSN All CDC
Submit
Healthcare-Associated Infections (HAIs)
* Narrative & Commentary
* Data Tables - Adult HAIs
* Data Tables - Pediatric HAIs
* Technical Resources
* Healthcare-Associated Infections (HAIs) Home
Healthcare-Associated Infections (HAIs)
Healthcare-Associated Infections (HAIs) Home
CDC's website is being modified to comply with President Trump's Executive Orders.
HAI Pathogens and Antimicrobial Resistance Report, 2018-2021
HAI Pathogens and Antimicrobial Resistance Report, 2018-2021
Adult Data Tables
Print
PAGE 14 of 19
‹View Table of Contents
Table 13. Percent of CLABSI Pathogens Reported From Oncology Units That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Threats1, by Mucosal Barrier Injury (MBI) Status, Adults, 2018-2021
Table 13. Percent of CLABSI Pathogens Reported From Oncology Units That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Threats, by Mucosal Barrier Injury (MBI) Status, Adults, 2018-2021
MBI-LCBIs Non-MBI LCBIs
Pathogen, Antimicrobial Phenotype2 # Reported % Tested %R # Reported % Tested %R
Urgent Threats Select Enterobacterales3 5,182 1,306
Carbapenem-resistant (CRE) 74.6 3.6 73.4 2.7
Serious Threats Select Enterobacterales4 4,605 1,094
Extended-spectrum cephalosporin-NS 81.5 32.5 83.7 22.4
Enterobacter spp. 546 195
Cefepime-NS 77.1 13.5 74.4 3.4
Enterococcus faecalis 609 361
Vancomycin-resistant (VRE) 86.5 5.9 89.8 2.5
Enterococcus faecium 1,535 439
Vancomycin-resistant (VRE) 88.8 72.0 92.3 64.7
Note: Refer to Technical Resources for more information about phenotype definitions, acronyms, and terms used in this table.
Footnotes:
1. As classified by CDC’s 2022 Special Report: COVID-19 U.S. Impact on Antimicrobial Resistance [PDF – 10.7 MB]
2. MBI-LCBIs cannot be reported with Acinetobacter spp., Pseudomonas aeruginosa, or Staphylococcus aureus pathogens. Therefore, antimicrobial resistance phenotypes for these pathogens are not shown.
3. Consists of E. coli, Klebsiella oxytoca, Klebsiella pneumoniae, Klebsiella aerogenes, and Enterobacter spp.
4. Consists of E. coli, Klebsiella oxytoca, and Klebsiella pneumoniae.
HAI Pathogens and Antimicrobial Resistance Report Data Tables 2018-2021 - Adult HAIs
1. HAI Pathogens and Antimicrobial Resistance Report 2018-2021 Data Tables - Adult HAIs
2. Table 1. Facilities Reporting at Least 1 HAI Pathogen to NHSN
3. Table 2. Frequency of Pathogens and HAI Events Reported to NHSN, by HAI Type
4. Table 3. The Top 15 HAI Pathogens Reported to NHSN
5. Table 4. The Top 15 CLABSI Pathogens Reported to NHSN, by Location Type
6. Table 5. The Top 15 CAUTI Pathogens Reported to NHSN, by Location Type
7. Table 6. The Top 15 PVAP Pathogens Reported to NHSN, by Facility Type
8. Table 7. Frequency of SSI Pathogens, by Surgical Category and SSI Type
9. Table 8. The Top 15 SSI Pathogens Reported to NHSN, by SSI Type
10. Table 9. The Top 15 SSI Pathogens Reported to NHSN Following Surgery Types with High Pathogen Volume
11. Table 10. The Top 15 SSI Pathogens Reported to NHSN Following Select Surgery Types with Low Pathogen Volume
12. Table 11. Percent of HAI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats1, by HAI Type
13. Table 12. Percent of CLABSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Location Type
14. ›Table 13. Percent of CLABSI Pathogens Reported From Oncology Units That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Threats, by Mucosal Barrier Injury (MBI) Status
15. Table 14. Percent of CAUTI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Location Type
16. Table 15. Percent of PVAP Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Facility Type
17. Table 16. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats for Surgical Categories with High Pathogen Volume
18. Table 17. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats for Select Surgical Categories with Low Pathogen Volume
19. Table 18. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by SSI Type
Last Reviewed: July 28, 2023
Source: Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Healthcare Quality Promotion (DHQP)
* Facebook
* Twitter
* LinkedIn
* Syndicate
home HAI Pathogens and Antimicrobial Resistance Report 2018-2021
* Narrative & Commentary
* Data Tables - Adult HAIs
* Data Tables - Pediatric HAIs
* Technical Resources
* About CDC
* Contact Us
* 800-232-4636
Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat RSS
* CONTACT CDC
Contact Us
Call 800-232-4636
Email Us
* ABOUT CDC
+ About CDC
+ Jobs
+ Funding
* POLICIES
+ Accessibility
+ External Links
+ Privacy
+ Policies
+ Web Policies
+ No Fear Act
+ FOIA
+ OIG
+ No Fear Act
+ Nondiscrimination
+ Vulnerability Disclosure Policy
+ CDC Archive
+ Public Health Publications
+ HHS.gov
+ USA.gov
* CONNECT WITH US
+ Facebook
+ Twitter
+ Instagram
+ LinkedIn
+ Youtube
+ Pinterest
+ Snapchat
+ Email
* LANGUAGES
+ Español
+ 繁體中文
+ Tiếng Việt
+ 한국어
+ Tagalog
+ Русский
+ العربية
+ Kreyòl Ayisyen
+ Français
+ Polski
+ Português
+ Italiano
+ Deutsch
+ 日本語
+ فارسی
+ English
* U.S. Department of Health & Human Services
* Accessibility
* External Links
* Privacy
* Policies
* Web Policies
* FOIA
* OIG
* No Fear Act
* FOIA
* Nondiscrimination
* OIG
* Vulnerability Disclosure Policy
* CDC Archive
* Public Health Publications
* HHS.gov
* USA.gov
Content Credential
×
This image was edited or created using GenAI (generative artificial intelligence).
Our experts review all images in an effort to ensure accuracy and quality before use.
Learn more about CDC's usage of GenAI.
Note: Comparison ignores leading/trailing whitespace and certain script/tracking codes. Word-level highlighting (optional above) only applies to changed lines.